Vir Biotechnology, Inc. VIR Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s unrealized gains on investments?
- Vir Biotechnology, Inc. (VIR) reported unrealized gains on investments of $325K in Q1 2026.
- How has Vir Biotechnology, Inc.'s unrealized gains on investments changed year-over-year?
- Vir Biotechnology, Inc.'s unrealized gains on investments decreased by 71.9% year-over-year, from $1.16M to $325K.
- What is the long-term trend for Vir Biotechnology, Inc.'s unrealized gains on investments?
- Over 2 years (2023 to 2025), Vir Biotechnology, Inc.'s unrealized gains on investments has grown at a 3.7% compound annual growth rate (CAGR), from $1.04M to $1.12M.